SBG
- Product code
- SBG
- Device name
- In Situ Polymerizing Peripheral Nerve Cap
- Device class
- Class 2
- 21 CFR
- 21 CFR 882.5260
- Medical specialty
- Neurology
- Marketing pathway
- 510(K)
- Flag
- Implant
- 510(k) clearances (last 3 years)
- 2
FDA classification definition
An in situ polymerizing peripheral nerve cap is a prescription use only device composed of precursor materials that polymerize when delivered to the end of a peripheral nerve to function as a physical barrier to the surrounding in vivo environment to reduce the risk of formation of a symptomatic neuroma.
510(k) clearances, last 3 years (2)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K252051 | 2025-09-29 | Tulavi Therapeutics, Inc. | allay Nerve Cap (TL5515-1); allay Nerve Cap (TL551 | |
| DEN230061 | 2024-07-16 | Tulavi Therapeutics | allay Nerve Cap | — |
Official FDA classification page: SBG
Classification and pathway per current FDA publications. Data from openFDA (CC0).